サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1769920

移植診断の世界市場：産業分析、市場規模・シェア・成長・動向・予測 (2025年～2035年)

Transplant Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

出版日
ページ情報
英文 265 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.48円
移植診断の世界市場：産業分析、市場規模・シェア・成長・動向・予測 (2025年～2035年)
出版日: 2025年05月08日
発行: Transparency Market Research
ページ情報: 英文 265 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

移植診断市場 - 分析範囲

TMRの調査レポート「世界の移植診断市場」は、2025年から2035年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2025年を基準年、2035年を予測年として、2019年から2035年までの世界の移植診断市場の収益と予測を提供します。また、2025年から2035年までの世界の移植診断市場の複合年間成長率（CAGR、%）も掲載しています。

当レポートは広範な調査を経て作成されています。一次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、移植診断市場を推察しました。

市場概況
市場規模（2024年） 78億米ドル
市場規模（2035年） 172億米ドル
CAGR 7.3%

当レポートでは、世界の移植診断市場の競合情勢について分析しています。世界の移植診断市場で事業を展開する主要企業が特定され、各企業がさまざまな属性でプロファイルされています。企業概要・財務状況・最新動向・SWOTが、当レポートで紹介されている世界の移植診断市場における各企業の属性です。

目次

第1章 序論

第2章 前提条件と分析手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の移植診断市場分析と予測（2020～2035年）

第5章 主要洞察

  • パイプライン分析
  • 主要製品/ブランド分析
  • 主要M&A
  • COVID-19による産業への影響

第6章 世界市場の分析と予測：スクリーニング別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測（金額ベース）：スクリーニング別（2020～2035年）
    • 移植前診断
    • 移植後診断
  • 市場の魅力：スクリーニング別

第7章 世界市場の分析と予測：種類別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測（金額ベース）：種類別（2020～2035年）
    • 分子アッセイ
    • 非分子アッセイ
  • 市場の魅力：技術別

第8章 世界市場の分析と予測：用途別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測（金額ベース）：用途別（2020～2035年）
    • 固形臓器移植
      • 腎臓
      • 肝臓
      • 心臓
      • 肺
      • 膵臓
      • 小腸
    • 幹細胞移植
  • 市場の魅力：用途別

第9章 世界市場の分析と予測：製品・サービス別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測（金額ベース）：製品・サービス別（2020～2035年）
    • 試薬・消耗品
    • 装置
    • ソフトウェア・サービス
  • 市場の魅力：製品・サービス別

第10章 世界市場の分析と予測：エンドユーザー別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測（金額ベース）：エンドユーザー別（2020～2035年）
    • 病院・移植センター
    • 研究室
    • その他
  • 市場の魅力：エンドユーザー別

第11章 世界市場の分析と予測：地域別

  • 主な分析結果
  • 市場予測（金額ベース）：地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力：地域別

第12章 北米市場の分析と予測

第13章 欧州市場の分析と予測

第14章 アジア太平洋市場の分析と予測

第15章 ラテンアメリカ市場の分析と予測

第16章 中東・アフリカ市場の分析と予測

第17章 競合情勢

  • 市場企業・競合マトリックス（企業の階層別・規模別）
  • 市場シェア分析：企業別（2024年）
  • 企業プロファイル
    • Bio-Rad laboratories, Inc.
    • Qiagen N.V.
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific, Inc.
    • Becton, Dickinson and Company
    • Ortho Clinical Diagnostics
    • Immucor, Inc.
    • Illumina, Inc.
    • Siemens Healthineers（Siemens AG）
    • Agilent Technologies
図表

List of Tables

  • Table 01: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031
  • Table 02: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031
  • Table 03: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031
  • Table 04: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031
  • Table 05: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031
  • Table 06: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017 to 2031
  • Table 07: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017 to 2031
  • Table 08: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031
  • Table 09: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031
  • Table 10: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031
  • Table 11: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031
  • Table 12: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031
  • Table 13: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017 to 2031
  • Table 14: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031
  • Table 15: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031
  • Table 16: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031
  • Table 17: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031
  • Table 18: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031
  • Table 19: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017 to 2031
  • Table 20: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031
  • Table 21: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031
  • Table 22: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031
  • Table 23: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031
  • Table 24: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031
  • Table 25: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017 to 2031
  • Table 26: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031
  • Table 27: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031
  • Table 28: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031
  • Table 29: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031
  • Table 30: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031
  • Table 31: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017 to 2031
  • Table 32: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031
  • Table 33: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031
  • Table 34: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031
  • Table 35: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031
  • Table 36: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031

List of Figures

  • Figure 01: Global Transplant Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031
  • Figure 02: Global Transplant Diagnostics Market Revenue (US$ Mn), by Screening, 2022
  • Figure 03: Global Transplant Diagnostics Market Value Share, by Screening, 2022
  • Figure 04: Global Transplant Diagnostics Market Revenue (US$ Mn), by Technique, 2022
  • Figure 05: Global Transplant Diagnostics Market Value Share, by Technique, 2022
  • Figure 06: Global Transplant Diagnostics Market Revenue (US$ Mn), by Application, 2022
  • Figure 07: Global Transplant Diagnostics Market Value Share, by Application, 2022
  • Figure 08: Global Transplant Diagnostics Market Revenue (US$ Mn), by Products & Services, 2022
  • Figure 09: Global Transplant Diagnostics Market Value Share, by Products & Services, 2022
  • Figure 10: Global Transplant Diagnostics Market Revenue (US$ Mn), by End-user, 2022
  • Figure 11: Global Transplant Diagnostics Market Value Share, by End-user, 2022
  • Figure 12: Global Transplant Diagnostics Market Value Share, by Region, 2022
  • Figure 13: Global Transplant Diagnostics Market Value (US$ Mn) Forecast, 2017 to 2031
  • Figure 14: Global Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 15: Global Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031
  • Figure 16: Global Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 17: Global Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031
  • Figure 18: Global Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 19: Global Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031
  • Figure 20: Global Transplant Diagnostics Market Revenue (US$ Mn), by Products & Services, 2022
  • Figure 21: Global Transplant Diagnostics Market Value Share, by Products & Services, 2022
  • Figure 22: Global Transplant Diagnostics Market Revenue (US$ Mn), by End-user, 2022
  • Figure 23: Global Transplant Diagnostics Market Value Share, by End-user, 2022
  • Figure 24: Global Transplant Diagnostics Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 25: Global Transplant Diagnostics Market Attractiveness Analysis, by Region, 2023 to 2031
  • Figure 26: North America Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017 to 2031
  • Figure 27: North America Transplant Diagnostics Market Attractiveness Analysis, by Country, 2023 to 2031
  • Figure 28: North America Transplant Diagnostics Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 29: North America Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 30: North America Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 31: North America Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 32: North America Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
  • Figure 33: North America Transplant Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031
  • Figure 34: North America Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031
  • Figure 35: North America Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031
  • Figure 36: North America Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031
  • Figure 37: North America Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023 to 2031
  • Figure 38: North America Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023 to 2031
  • Figure 39: Europe Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017 to 2031
  • Figure 40: Europe Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023 to 2031
  • Figure 41: Europe Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 42: Europe Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 43: Europe Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 44: Europe Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 45: Europe Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
  • Figure 46: Europe Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 47: Europe Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031
  • Figure 48: Europe Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031
  • Figure 49: Europe Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031
  • Figure 50: Europe Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023 to 2031
  • Figure 51: Europe Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023 to 2031
  • Figure 52: Asia Pacific Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017 to 2031
  • Figure 53: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023 to 2031
  • Figure 54: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 55: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 56: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 57: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 58: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
  • Figure 59: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 60: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031
  • Figure 61: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031
  • Figure 62: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031
  • Figure 63: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023 to 2031
  • Figure 64: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023 to 2031
  • Figure 65: Latin America Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017 to 2031
  • Figure 66: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023 to 2031
  • Figure 67: Latin America Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 68: Latin America Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 69: Latin America Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 70: Latin America Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 71: Latin America Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
  • Figure 72: Latin America Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 73: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031
  • Figure 74: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031
  • Figure 75: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031
  • Figure 76: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023 to 2031
  • Figure 77: Latin America Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023 to 2031
  • Figure 78: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017 to 2031
  • Figure 79: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023 to 2031
  • Figure 80: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 81: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 82: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 83: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 84: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
  • Figure 85: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 86: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031
  • Figure 87: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031
  • Figure 88: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031
  • Figure 89: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023 to 2031
  • Figure 90: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023 to 2031
目次
Product Code: TMRGL20225

Transplant Diagnostics Market - Scope of Report

TMR's report on the global transplant diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global transplant diagnostics market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global transplant diagnostics market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the transplant diagnostics market.

Market Snapshot
Market Value in 2024US$ 7.8 Bn
Market Value in 2035US$ 17.2 Bn
CAGR7.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global transplant diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global transplant diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global transplant diagnostics market.

The report delves into the competitive landscape of the global transplant diagnostics market. Key players operating in the global transplant diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global transplant diagnostics market profiled in this report.

Key Questions Answered in Global transplant diagnostics Market Report:

  • What is the sales/revenue generated by transplant diagnostics across all regions during the forecast period?
  • What are the opportunities in the global transplant diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Transplant Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global transplant diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global transplant diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global transplant diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Transplant Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Transplant Diagnostics Market Analysis and Forecast, 2017 to 2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Transplant Diagnostics Market Analysis and Forecast, by Screening

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Screening, 2017 to 2031
    • 6.3.1. Pre-transplant Diagnostics
    • 6.3.2. Post-transplant Diagnostics
  • 6.4. Market Attractiveness, by Screening

7. Global Transplant Diagnostics Market Analysis and Forecast, by Technique

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technique, 2017 to 2031
    • 7.3.1. Molecular Assay
    • 7.3.2. Non-molecular Assay
    • 7.3.3. 7.4 Market Attractiveness, by Technique

8. Global Transplant Diagnostics Market Analysis and Forecast, by Application

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2017 to 2031
    • 8.3.1. Solid Organ Transplantation
      • 8.3.1.1. Kidney
      • 8.3.1.2. Liver
      • 8.3.1.3. Heart
      • 8.3.1.4. Lungs
      • 8.3.1.5. Pancreas
      • 8.3.1.6. Small Bowel
    • 8.3.2. Stem Cell Transplantation
  • 8.4. Market Attractiveness, by Application

9. Global Transplant Diagnostics Market Analysis and Forecast, by Products & Services

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Products & Services, 2017 to 2031
    • 9.3.1. Reagents & Consumables
    • 9.3.2. Instruments
    • 9.3.3. Software & Services
  • 9.4. Market Attractiveness, by Products & Services

10. Global Transplant Diagnostics Market Analysis and Forecast, by End-user

  • 10.1. Introduction and Definitions
  • 10.2. Key Findings/Developments
  • 10.3. Market Value Forecast, by End-user, 2017 to 2031
    • 10.3.1. Hospitals & Transplant Centers
    • 10.3.2. Research Laboratories
    • 10.3.3. Others
  • 10.4. Market Attractiveness, by End-user

11. Global Transplant Diagnostics Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region, 2017 to 2031
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness, by Region

12. North America Transplant Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Screening, 2017 to 2031
    • 12.2.1. Pre-transplant Diagnostics
    • 12.2.2. Post-transplant Diagnostics
  • 12.3. Market Attractiveness, by Screening
  • 12.4. Market Value Forecast, by Technique, 2017 to 2031
    • 12.4.1. Molecular Assay
    • 12.4.2. Non-molecular Assay
  • 12.5. Market Attractiveness, by Technique
  • 12.6. Market Value Forecast, by Application, 2017 to 2031
    • 12.6.1. Solid Organ Transplantation
      • 12.6.1.1. Kidney
      • 12.6.1.2. Liver
      • 12.6.1.3. Heart
      • 12.6.1.4. Lungs
      • 12.6.1.5. Pancreas
      • 12.6.1.6. Small Bowel
    • 12.6.2. Stem Cell Transplantation
  • 12.7. Market Attractiveness, by Application
  • 12.8. Market Value Forecast, by Products & Services, 2017 to 2031
    • 12.8.1. Reagents & Consumables
    • 12.8.2. Instruments
    • 12.8.3. Software & Services
  • 12.9. Market Attractiveness, by Products & Services
  • 12.10. Market Value Forecast, by End-user, 2017 to 2031
    • 12.10.1. Hospitals & Transplant Centers
    • 12.10.2. Research Laboratories
    • 12.10.3. Others
  • 12.11. Market Attractiveness, by End-user
  • 12.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031
    • 12.12.1. U.S.
    • 12.12.2. Canada
  • 12.13. Market Attractiveness Analysis
    • 12.13.1. By Screening
    • 12.13.2. By Technique
    • 12.13.3. By Application
    • 12.13.4. By Products & Services
    • 12.13.5. By End-user
    • 12.13.6. By Country

13. Europe Transplant Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Screening, 2017 to 2031
    • 13.2.1. Pre-transplant Diagnostics
    • 13.2.2. Post-transplant Diagnostics
  • 13.3. Market Attractiveness, by Screening
  • 13.4. Market Value Forecast, by Technique, 2017 to 2031
    • 13.4.1. Molecular Assay
    • 13.4.2. Non-molecular Assay
  • 13.5. Market Attractiveness, by Technique
  • 13.6. Market Value Forecast, by Application, 2017 to 2031
    • 13.6.1. Solid Organ Transplantation
      • 13.6.1.1. Kidney
      • 13.6.1.2. Liver
      • 13.6.1.3. Heart
      • 13.6.1.4. Lungs
      • 13.6.1.5. Pancreas
      • 13.6.1.6. Small Bowel
    • 13.6.2. Stem Cell Transplantation
  • 13.7. Market Attractiveness, by Application
  • 13.8. Market Value Forecast, by Products & Services, 2017 to 2031
    • 13.8.1. Reagents & Consumables
    • 13.8.2. Instruments
    • 13.8.3. Software & Services
  • 13.9. Market Attractiveness, by Products & Services
  • 13.10. Market Value Forecast, by End-user, 2017 to 2031
    • 13.10.1. Hospitals & Transplant Centers
    • 13.10.2. Research Laboratories
    • 13.10.3. Others
  • 13.11. Market Attractiveness, by End-user
  • 13.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031
    • 13.12.1. Germany
    • 13.12.2. U.K.
    • 13.12.3. France
    • 13.12.4. Italy
    • 13.12.5. Spain
    • 13.12.6. Rest of Europe
  • 13.13. Market Attractiveness Analysis
    • 13.13.1. By Screening
    • 13.13.2. By Technique
    • 13.13.3. By Application
    • 13.13.4. By Products & Services
    • 13.13.5. By End-user
    • 13.13.6. By Country/Sub-region

14. Asia Pacific Transplant Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Screening, 2017 to 2031
    • 14.2.1. Pre-transplant Diagnostics
    • 14.2.2. Post-transplant Diagnostics
  • 14.3. Market Attractiveness, by Screening
  • 14.4. Market Value Forecast, by Technique, 2017 to 2031
    • 14.4.1. Molecular Assay
    • 14.4.2. Non-molecular Assay
  • 14.5. Market Attractiveness, by Technique
  • 14.6. Market Value Forecast, by Application, 2017 to 2031
    • 14.6.1. Solid Organ Transplantation
      • 14.6.1.1. Kidney
      • 14.6.1.2. Liver
      • 14.6.1.3. Heart
      • 14.6.1.4. Lungs
      • 14.6.1.5. Pancreas
      • 14.6.1.6. Small Bowel
    • 14.6.2. Stem Cell Transplantation
  • 14.7. Market Attractiveness, by Application
  • 14.8. Market Value Forecast, by Products & Services, 2017 to 2031
    • 14.8.1. Reagents & Consumables
    • 14.8.2. Instruments
    • 14.8.3. Software & Services
  • 14.9. Market Attractiveness, by Products & Services
  • 14.10. Market Value Forecast, by End-user, 2017 to 2031
    • 14.10.1. Hospitals & Transplant Centers
    • 14.10.2. Research Laboratories
    • 14.10.3. Others
  • 14.11. Market Attractiveness, by End-user
  • 14.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031
    • 14.12.1. China
    • 14.12.2. Japan
    • 14.12.3. India
    • 14.12.4. Australia & New Zealand
    • 14.12.5. Rest of Asia Pacific
  • 14.13. Market Attractiveness Analysis
    • 14.13.1. By Screening
    • 14.13.2. By Technique
    • 14.13.3. By Application
    • 14.13.4. By Products & Services
    • 14.13.5. By End-user
    • 14.13.6. By Country/Sub-region

15. Latin America Transplant Diagnostics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Screening, 2017 to 2031
    • 15.2.1. Pre-transplant Diagnostics
    • 15.2.2. Post-transplant Diagnostics
  • 15.3. Market Attractiveness, by Screening
  • 15.4. Market Value Forecast, by Technique, 2017 to 2031
    • 15.4.1. Molecular Assay
    • 15.4.2. Non-molecular Assay
  • 15.5. Market Attractiveness, by Technique
  • 15.6. Market Value Forecast, by Application, 2017 to 2031
    • 15.6.1. Solid Organ Transplantation
      • 15.6.1.1. Kidney
      • 15.6.1.2. Liver
      • 15.6.1.3. Heart
      • 15.6.1.4. Lungs
      • 15.6.1.5. Pancreas
      • 15.6.1.6. Small Bowel
    • 15.6.2. Stem Cell Transplantation
  • 15.7. Stem Cell Transplantation Market Attractiveness, by Application
  • 15.8. Market Value Forecast, by Products & Services, 2017 to 2031
    • 15.8.1. Reagents & Consumables
    • 15.8.2. Instruments
    • 15.8.3. Software & Services
  • 15.9. Market Attractiveness, by Products & Services
  • 15.10. Market Value Forecast, by End-user, 2017 to 2031
    • 15.10.1. Hospitals & Transplant Centers
    • 15.10.2. Research Laboratories
    • 15.10.3. Others
  • 15.11. Market Attractiveness, by End-user
  • 15.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031
    • 15.12.1. Brazil
    • 15.12.2. Mexico
    • 15.12.3. Rest of Latin America
  • 15.13. Market Attractiveness Analysis
    • 15.13.1. By Screening
    • 15.13.2. By Technique
    • 15.13.3. By Application
    • 15.13.4. By Products & Services
    • 15.13.5. By End-user
    • 15.13.6. By Country/Sub-region

16. Middle East & Africa Transplant Diagnostics Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Screening, 2017 to 2031
    • 16.2.1. Pre-transplant Diagnostics
    • 16.2.2. Post-transplant Diagnostics
  • 16.3. Market Attractiveness, by Screening
  • 16.4. Market Value Forecast, by Technique, 2017 to 2031
    • 16.4.1. Molecular Assay
    • 16.4.2. Non-molecular Assay
  • 16.5. Market Attractiveness, by Technique
  • 16.6. Market Value Forecast, by Application, 2017 to 2031
    • 16.6.1. Solid Organ Transplantation
      • 16.6.1.1. Kidney
      • 16.6.1.2. Liver
      • 16.6.1.3. Heart
      • 16.6.1.4. Lungs
      • 16.6.1.5. Pancreas
      • 16.6.1.6. Small Bowel
    • 16.6.2. Stem Cell Transplantation
  • 16.7. Market Attractiveness, by Application
  • 16.8. Market Value Forecast, by Products & Services, 2017 to 2031
    • 16.8.1. Reagents & Consumables
    • 16.8.2. Instruments
    • 16.8.3. Software & Services
  • 16.9. Market Attractiveness, by Products & Services
  • 16.10. Market Value Forecast, by End-user, 2017 to 2031
    • 16.10.1. Hospitals & Transplant Centers
    • 16.10.2. Research Laboratories
    • 16.10.3. Others
  • 16.11. Market Attractiveness, by End-user
  • 16.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031
    • 16.12.1. GCC Countries
    • 16.12.2. South Africa
    • 16.12.3. Rest of Middle East & Africa
  • 16.13. Market Attractiveness Analysis
    • 16.13.1. By Screening
    • 16.13.2. By Technique
    • 16.13.3. By Application
    • 16.13.4. By Products & Services
    • 16.13.5. By End-user
    • 16.13.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 17.2. Market Share Analysis, by Company (2022)
  • 17.3. Company Profiles
    • 17.3.1. Bio-Rad laboratories, Inc.
      • 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.1.2. Product Portfolio
      • 17.3.1.3. Financial Overview
      • 17.3.1.4. SWOT Analysis
      • 17.3.1.5. Strategic Overview
    • 17.3.2. Qiagen N.V.
      • 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.2.2. Product Portfolio
      • 17.3.2.3. Financial Overview
      • 17.3.2.4. SWOT Analysis
      • 17.3.2.5. Strategic Overview
    • 17.3.3. F. Hoffmann-La Roche AG
      • 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.3.2. Product Portfolio
      • 17.3.3.3. Financial Overview
      • 17.3.3.4. SWOT Analysis
      • 17.3.3.5. Strategic Overview
    • 17.3.4. Thermo Fisher Scientific, Inc.
      • 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.4.2. Product Portfolio
      • 17.3.4.3. Financial Overview
      • 17.3.4.4. SWOT Analysis
      • 17.3.4.5. Strategic Overview
    • 17.3.5. Becton, Dickinson and Company
      • 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.5.2. Product Portfolio
      • 17.3.5.3. Financial Overview
      • 17.3.5.4. SWOT Analysis
      • 17.3.5.5. Strategic Overview
    • 17.3.6. Ortho Clinical Diagnostics
      • 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.6.2. Product Portfolio
      • 17.3.6.3. Financial Overview
      • 17.3.6.4. SWOT Analysis
      • 17.3.6.5. Strategic Overview
    • 17.3.7. Immucor, Inc.
      • 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.7.2. Product Portfolio
      • 17.3.7.3. Financial Overview
      • 17.3.7.4. SWOT Analysis
      • 17.3.7.5. Strategic Overview
    • 17.3.8. Illumina, Inc.
      • 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.8.2. Product Portfolio
      • 17.3.8.3. Financial Overview
      • 17.3.8.4. SWOT Analysis
      • 17.3.8.5. Strategic Overview
    • 17.3.9. Siemens Healthineers (Siemens AG)
      • 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.9.2. Product Portfolio
      • 17.3.9.3. Financial Overview
      • 17.3.9.4. SWOT Analysis
      • 17.3.9.5. Strategic Overview
    • 17.3.10. Agilent Technologies
      • 17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.10.2. Product Portfolio
      • 17.3.10.3. Financial Overview
      • 17.3.10.4. SWOT Analysis
      • 17.3.10.5. Strategic Overview